National Cancer Institute (NCI)

Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaboration (2016) Permuth JB, Reid B, Earp M, Chen YA, Monteiro ANA, Chen Z, Chenevix-Trench G, et al. Journal article Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation (2016) Ghoussaini M, French JD, Michailidou K, Nord S, Beesley J, Canisus S, Hillman KM, et al. Journal article Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer (2016) Shi J, Zhang Y, Zheng W, Michailidou K, Ghoussaini M, Bolla MK, Wang Q, et al. Journal article Genetic predisposition to ductal carcinoma in situ of the breast (2016) Petridis C, Brook MN, Shah V, Kohut K, Gorman P, Caneppele M, Levi D, et al. Journal article Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry (2016) Zhao Z, Wen W, Michailidou K, Bolla MK, Wang Q, Zhang B, Long J, et al. Journal article Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study (2016) Dixon SC, Nagle CM, Thrift AP, Pharoah PDP, Pearce CL, Zheng W, Painter JN, et al. Journal article Patient survival and tumor characteristics associated with CHEK2:p.I157T - findings from the Breast Cancer Association Consortium (2016) Muranen TA, Blomqvist C, Doerk T, Jakubowska A, Heikkila P, Fagerholm R, Greco D, et al. Journal article Macrophage-derived nitric oxide initiates T-cell diapedesis and tumor rejection (2016) Sektioglu IM, Carretero R, Bender N, Bogdan C, Garbi N, Umansky V, Umansky L, et al. Journal article Diabetes-linked transcription factor HNF4? regulates metabolism of endogenous methylarginines and ?-aminoisobutyric acid by controlling expression of alanine-glyoxylate aminotransferase 2 (2016) Burdin DV, Kolobov AA, Brocker C, Soshnev AA, Samusik N, Demyanov AV, Brilloff S, et al. Journal article Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer (2016) Hampras SS, Sucheston-Campbell LE, Cannioto R, Chang-Claude J, Modugno F, Doerk T, Hillemanns P, et al. Journal article